Skip to main content

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Introduction

In an order issued on February 6, Arkansas federal Judge Timothy Brooks denied summary judgment request filed by Smith &  Nephew in a lawsuit involving its Synergy Stem artificial hip, finding questions of fact whether the hip system had a manufacturing and/ or compositional defect at the time it was implanted.

Judge Timothy Brooks refused to exclude the testimony provided by the plaintiff's expert witnesses and stated that the expert witnesses were qualified enough to have an opinion on metallurgy and damages. The plaintiff, John Myatt, underwent a hip replacement surgery in 2004, following a fatal car accident, and he was implanted with Smith & Nephew's Synergy Stem.

Smith & Nephew manufactures several hip replacement systems meant to increase mobility and improve durability. However, the company's metal-on-metal implants were linked to serious complications like metallosis. The company faces more than 500 hip implant lawsuits which are consolidated into federal litigation. Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and DePuy Synthes.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!